Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
American Journal of Clinical Pathology
|
June 14, 2014
High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma
Ester Alvino, Francesca Passarelli, Elda Cannavò, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 23, 2019
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Simona Caporali, Adriana Amaro, Lauretta Levati, et al.
Biomedicines
|
December 24, 2021
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
Anna Tosi, Lavinia Nardinocchi, Maria Luigia Carbone, et al.
Scientific Reports
|
April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2021
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients
Sofia Verkhovskaia, Francesca Romana Di Pietro, Simona Mastroeni, et al.
Cancers
|
April 14, 2026
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis
Alessia Capone, Maria Luigia Carbone, Simona Mastroeni, et al.
Frontiers in Medicine
|
November 5, 2024
Implementing a group singing intervention for postpartum depression within the Italian health service
Ilaria Lega, Ilaria Luzi, Simona Mastroeni, et al.
Cancers
|
August 12, 2022
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
Lauretta Levati, Cristian Bassi, Simona Mastroeni, et al.
Journal of Biomedical Science
|
February 26, 2026
TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes
Valeria Bartolocci, Alessio Capone, Rosanna Monetta, et al.
The British Journal of Dermatology
|
May 31, 2024
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Alessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
American Journal of Clinical Pathology
|
June 14, 2014
High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma
Ester Alvino, Francesca Passarelli, Elda Cannavò, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 23, 2019
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Simona Caporali, Adriana Amaro, Lauretta Levati, et al.
Biomedicines
|
December 24, 2021
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
Anna Tosi, Lavinia Nardinocchi, Maria Luigia Carbone, et al.
Scientific Reports
|
April 1, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2021
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients
Sofia Verkhovskaia, Francesca Romana Di Pietro, Simona Mastroeni, et al.
Cancers
|
April 14, 2026
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis
Alessia Capone, Maria Luigia Carbone, Simona Mastroeni, et al.
Frontiers in Medicine
|
November 5, 2024
Implementing a group singing intervention for postpartum depression within the Italian health service
Ilaria Lega, Ilaria Luzi, Simona Mastroeni, et al.
Cancers
|
August 12, 2022
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
Lauretta Levati, Cristian Bassi, Simona Mastroeni, et al.
Journal of Biomedical Science
|
February 26, 2026
TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes
Valeria Bartolocci, Alessio Capone, Rosanna Monetta, et al.
The British Journal of Dermatology
|
May 31, 2024
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Alessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
Page
of 7